The North America Thyroid Function Testing Market would witness market growth of 5.7% CAGR during the forecast period (2023-2031).
The US market dominated the North America Thyroid Function Testing Market by Country in 2023 and would continue to be a dominant market till 2031; thereby, achieving a market value of $2,070.5 million by 2031. The Canada market is experiencing a CAGR of 8.1% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 7.2% during (2024 - 2031).
The market is pivotal in diagnosing and managing thyroid disorders, affecting millions. It encompasses a range of diagnostic assays and methodologies to evaluate the thyroid glands hormone production and regulatory functions. From routine screening to monitoring treatment response, this is indispensable in clinical practice, catering to diverse patient populations across various healthcare settings.
Thyroid function testing has many applications in clinical practice, playing a crucial role in diagnosing, managing, and monitoring thyroid disorders. For example, thyroid function tests are commonly used for population-wide screening to detect thyroid dysfunction, including hypothyroidism, hyperthyroidism, and thyroid nodules. Screening helps identify individuals at risk of thyroid disorders, facilitating early diagnosis and intervention to prevent complications.
High rates of thyroid cancer in Canada may lead to increased awareness and screening for thyroid disorders, including routine testing. The Canadian Cancer Society reports that 6,300 Canadians were diagnosed with thyroid cancer, and 270 Canadians lost their lives to the disease in 2023. Among them, 1,900 men were diagnosed with thyroid cancer, and 120 died from it. In conclusion, the high rates of thyroid cancer and increasing awareness about thyroid disorders are driving the growth of the market.
Free Valuable Insights: The Thyroid Function Testing Market is Predict to reach USD 7.5 Billion by 2031, at a CAGR of 6.4%
Based on End-use, the market is segmented into Hospitals, Diagnostic Laboratories, Clinics, and Research Laboratories & Institutes. Based on Test Type, the market is segmented into TSH Test, Free T4 Test, T4 Test, T3 Test, Free T3 Test, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
By End-use
By Test Type
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
